Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: Relation to gastric mucosal ascorbic acid concentrations and effect of H pylori eradication

Gut

Volumn 42, Issue 6, 1998, Pages 768-771

  Drake, I M ^a   Mapstone, N P ^a   Schorah, C J ^a   White, K L M ^a   Chalmers, D M ^a   Dixon, M F ^a   Axon, A T R ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Ascorbic acid; Gastric cancer; Helicobacter pylori; Reactive oxygen species

Indexed keywords

ASCORBIC ACID;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; STOMACH CANCER; VITAMIN INTAKE;

EID: 0031862831     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.6.768     Document Type: Article

References (34)

1. Rowley DA, Gutteridge JMC, Blake DR, et al. Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci 1984;66:691-5.
2. Keshavarzian A, Sedghi S, Kanofski J, et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 1992;103:177-85.
3. Shacter E, Beecham EJ, Covey JM, et al. Activated neutrophils induce prolonged DNA damage in neighbouring cells. Carcinogenesis 1988;9:2297-304.
4. Schraufstatter I, Hyslop PA, Jackson JH, et al. Oxidant induced DNA damage of target cells. J Clin Invest 1988;82: 1040-50.
5. Weitberg AB, Weitzman SA, Destrempes M, et al. Stimulated human phagocytes produced cytogenetic changes in cultured mammalian cells. N Engl J Med 1983; 308:26-30.
6. Barak M, Ulizur S, Merzbach D. Phagocytosis induced mutagenesis in bacteria. Mutat Res 1983;121:7-16.
7. Farr SB, D'Ari R, Touati D. Oxygen dependent mutagenesis in E coli lacking SOD. Proc Natl Acad Sci USA 1986;83:8268-72.
8. Fulton AH, Lovelas SE, Heppner GH. Mutagenic activity of tumour associated macrophages in Salmonella typhimurium strains TA 98 and TA 100. Cancer Res 1984;44:4308-11.
9. Weitzman SA, Stossel TP. Phagocyte induced mutation in Chinese hamster ovary cells. Cancer Lett 1984;22:337-42.
10. Hsie AW, Reizo L, Katz S, et al. Evidence for reactive oxygen species inducing mutations in mammalian cells. Proc Natl Acad Sci USA 1986;83:9616-20.
11. Ziegler-Skylakis K, Andre U. Mutagenicity of hydrogen peroxide in V79 Chinese hamster cells. Mutat Res 1987;192: 65-7.
12. Yamashina K, Miller B, Heppner GH. Macrophage mediated induction of drug resistant variants in a mouse mammary tumour cell line. Cancer Res 1986;46:2396-400.
13. Weitzman SA, Weitberg AB, Clark EP, et al. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 1985;227:1231-3.
14. Forman D, Newell DG, Fullerton F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from prospective investigation. BMJ 1991;302:1302-5.
15. Parsonnet J, Friedman GD, Vanderstern DP. Helicobacter pylori and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
16. Nomura A, Stemmerman GN, Glyou PH. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
17. IARC-WHO. The evolution of carcinogenic risks in humans. Monograph 62. Lyon, France: International Agency for Research on Cancer, 1994.
18. Rautelin H, Blonberg B, Fredlund H, et al. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 1993;34:599-603.
19. Davies GR, Simmonds NJ, Stevens TRJ, et al. Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992;33:1467-72.
20. Davies GR, Simmonds NJ, Stevens TRJ, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994;35:179-85.
21. Ramon JM, Serra-Majem L, Cerdo C, et al. Nutrient intake and gastric cancer risk: a case-controlled study in Spain. Int J Epidemiol 1993;22:983-8.
22. Buiatti E, Palli D, Decorli A, et al. A case control study of gastric cancer and diet in Italy: II Association with nutrients. Int J Cancer 1990;45:896-901.
23. Whitehead JP, Thorpe GHG, Masarell SRJ. Enhanced chemiluminescence assay for antioxidant capacity in biological fluids. Analytical Chimica Acta 1992;266:265-77.
24. Frei B. Ascorbic acid protects lipids in human plasma and low density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54:1113S-8S.
25. Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology 1989;97:357-63.
26. Sobala GM, Pignatelli B, Schorah CJ, et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 1991;12:193-8.
27. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212-16.
28. Waring AJ, Drake IM, Schorah CJ, et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice and gastric intestinal mucosa: effects of gastritis and oral supplementation. Gut 1996;38:171-6.
29. Lynch DAF, Mapstone NP, Clarke AMT, et al. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and the post-surgical stomach. Gut 1994;35:S34.
30. Cadenas E, Sies H. Low level chemiluminescence as an indicator of singlet oxygen in biological systems. Methods Enzymol 1984;105:221-31.
31. Vilim V, Wilhelm J. What do we measure by a luminol-dependent chemiluminescence of phagocytes? Free Radic Biol Med 1989;6:623-9.
32. Rathbone BJ, Johnson AW, Wyatt JI, et al. Ascorbic acid: a factor concentrated in human gastric juice. Clin Sci 1989;76:237-41.
33. Schorah CJ. The transport of vitamin C and effects of disease. Proc Nutr Soc 1992;51:189-98.
34. Sanderson MJ, White KLM, Drake IM, et al. Vitamin E and carotenoids in gastric biopsies: the relation to plasma concentrations in patients with and without Helicobacter pylori gastritis. Am J Clin Nutr 1997;65:101-6.